Techlongevity a Pioneer on the longevity biotechnology industry
Swiss AI Biotechnology Startup working in technologies to expand longevity and gathering a giant trusted cloud of human identity genome sequences for a longer and healthier life.
Swiss AI Biotechnology Startup working in technologies to expand longevity and gathering a giant trusted cloud of human identity genome sequences for a longer and healthier life.
Techlongevity Swiss AI Biotechnology Startup in artificial intelligence for drug discovery and biomarker development, academic excellence, extensive collaborations with pharmaceutical and consumer companies to build a business model in the nascent longevity biotechnology industry . Chronic diseases of aging have over the past century taken over from infectious diseases as the predominant causes of death and suffering. The science of aging has shown over the past few decades that certain slow biological changes collectively underlie most chronic diseases.
The aging and longevity field, the understanding of these slow changes and how to interfere with them, is currently a small part of the overall medical, healthcare, and biotech spaces, but the efficiency of targeting the underlying causes of multiple diseases will rapidly cause aging to grow to become a much larger portion.